#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13354	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2138	620.8	0	.	n	.	0	C451T	SNP	451	451	C	719	719	T	779	T,C	368,366	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13354	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2138	620.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1452	1452	C	730	C	688	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3617	661.5	0	.	n	.	0	T695C	SNP	695	695	T	1037	1037	C	668	C	629	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3617	661.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2313	2313	C	821	C,T	760,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3617	661.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2387	2387	A	785	A	746	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23986	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3617	661.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2939	2939	C	701	C	674	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1802	folP	855	855	100.0	folP.l15.c4.ctg.1	1525	117.4	1	SNP	p	R229S	1	.	.	685	687	AGC	990	992	AGC	188;187;185	A;G;C	181;179;177	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3464	139.9	1	SNP	p	S91F	1	.	.	271	273	TTC	653	655	TTC	166;167;167	T;T;C	159;161;157	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3464	139.9	1	SNP	p	G95N	0	.	.	283	285	GGC	665	667	GGC	161;158;159	G;G;C,T	151;147;147,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4864	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3464	139.9	1	SNP	p	D95G	1	.	.	283	285	GGC	665	667	GGC	161;158;159	G;G;C,T	151;147;147,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1450	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1337	108.1	1	SNP	p	G45D	0	.	.	133	135	GGC	479	481	GGC	186;186;187	G;G;C	174;175;178	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	776	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1095	70.6	0	.	n	.	0	A197.	DEL	197	197	A	650	650	A	180	A	172	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5310	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3037	174.2	1	SNP	p	D86N	0	.	.	256	258	GAC	538	540	GAC	226;225;226	G;A;C	218;217;220	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5310	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3037	174.2	1	SNP	p	R87I	0	.	.	259	261	CGT	541	543	CGT	227;223;224	C;G;T	221;214;210	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5310	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3037	174.2	1	SNP	p	R87W	0	.	.	259	261	CGT	541	543	CGT	227;223;224	C;G;T	221;214;210	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5310	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3037	174.2	1	SNP	p	S87R	1	.	.	259	261	CGT	541	543	CGT	227;223;224	C;G;T	221;214;210	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5310	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3037	174.2	1	SNP	p	S88P	0	.	.	262	264	TCC	544	546	TCC	225;226;227	T;C;C	217;217;220	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3746	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2677	139.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1528	1530	GGC	160;161;161	G;G;C	145;147;145	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1279	1281	GCC	186;187;187	G;C;C	174;175;175	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1282	1284	ATG	190;191;192	A;T;G	176;177;176	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1294	1296	ACC	185;186;187	A;C;C	173;178;179	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1294	1296	ACC	185;186;187	A;C;C	173;178;179	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1795	1797	ACC	194;195;197	A;C;C	176;183;186	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1849	1851	GCG	215;214;212	G;C;G	207;206;204	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1849	1851	GCG	215;214;212	G;C;G	207;206;204	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1972	1974	GGT	167;165;164	G;G;T	154;156;154	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1981	1983	AGC	159;159;158	A;G;C	145;145;143	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3510	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	144.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1999	2001	CCG	142;143;141	C,G;C;GCCC,GGGCCCC	117,3;118;108,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5306	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3123	169.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1644	1646	CCG	225;226;226	C;C;G	198;203;199	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2202	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1745	125.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	149	C	139	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2608	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1821	142.3	0	.	p	.	0	E209K	NONSYN	625	627	GAA	1134	1136	AAA	217;217;220	A;A;A	206;205;209	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2608	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1821	142.3	0	.	p	.	0	A212E	NONSYN	634	636	GCA	1143	1145	GAA	213;212;212	G;A;A	201;200;202	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2608	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1821	142.3	0	.	p	.	0	S255N	NONSYN	763	765	AGC	1272	1274	AAC	232;233;236	A;A;C	217;217;218	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2608	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1821	142.3	1	SNP	p	G120K	1	.	.	358	360	AAG	867	869	AAG	213;213;210	A;A;G	206;206;200	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2608	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1821	142.3	1	SNP	p	A121N	1	.	.	361	363	AAC	870	872	AAC	207;204;206	A;A;C	200;196;195	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2608	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1821	142.3	1	SNP	p	N121D	0	.	.	361	363	AAC	870	872	AAC	207;204;206	A;A;C	200;196;195	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9600	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5044	189.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1144	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1003	112.6	1	SNP	p	V57M	1	.	.	169	171	ATG	478	480	ATG	204;206;207	A;T;G	189;192;191	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
